Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.

Reset all filters
01 3Curia Italy S.r.l.
02 1Curia Italy s.r.l
03 1AbbVie Inc.
04 1TAPI Czech Industries s.r.o.
05 1CKD Bio Corporation
06 2Concord Biotech Limited
07 1Fujian Kerui Pharmaceutical Co., Ltd.
08 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
09 1Joyang Laboratories
10 1KALCHEM INTERNATIONAL INC
11 1LETCO MEDICAL, LLC
12 1Medisca Inc.
13 1North China Pharmaceutical Huasheng Co. Ltd.
14 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
15 1Professional Compounding Centers of America
16 1Sterling Pharma Solutions Limited
17 1Teva Czech Industries s.r.o
18 1Zhejiang Ruibang Laboratories
Reset all filters
01 8CYCLOSPORINE
02 1CYCLOSPORINE A
03 1Ciclosporin
04 10Cyclosporine
05 1Cyclosporine A
Reset all filters
01 5China
02 2India
03 2Israel
04 1South Korea
05 8U.S.A
06 3United Kingdom
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
NDC Package Code : 55486-1567
Start Marketing Date : 2012-06-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0074-5503
Start Marketing Date : 2010-05-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 84644-004
Start Marketing Date : 2022-01-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
NDC Package Code : 55486-1602
Start Marketing Date : 2012-06-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
NDC Package Code : 55486-1603
Start Marketing Date : 2012-06-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
NDC Package Code : 55486-1604
Start Marketing Date : 2021-11-04
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0660
Start Marketing Date : 2014-07-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 51927-0160
Start Marketing Date : 2003-08-19
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 50384-6300
Start Marketing Date : 2023-07-03
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (307kg/307kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 47848-004
Start Marketing Date : 2022-01-26
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT

78
PharmaCompass offers a list of Cyclosporine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyclosporine manufacturer or Cyclosporine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyclosporine manufacturer or Cyclosporine supplier.
PharmaCompass also assists you with knowing the Cyclosporine API Price utilized in the formulation of products. Cyclosporine API Price is not always fixed or binding as the Cyclosporine Price is obtained through a variety of data sources. The Cyclosporine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Restasis manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Restasis, including repackagers and relabelers. The FDA regulates Restasis manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Restasis API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Restasis manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Restasis supplier is an individual or a company that provides Restasis active pharmaceutical ingredient (API) or Restasis finished formulations upon request. The Restasis suppliers may include Restasis API manufacturers, exporters, distributors and traders.
click here to find a list of Restasis suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Restasis as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Restasis API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Restasis as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Restasis and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Restasis NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Restasis suppliers with NDC on PharmaCompass.
We have 16 companies offering Restasis
Get in contact with the supplier of your choice: